# ENDONOVO THERAPEUTICS, INC. — Regulation A 1-A/A

ENDONOVO THERAPEUTICS, INC. of Woodland Hills, CA filed a Regulation A 1-A/A with the SEC on 2023-08-25. Aggregate offering: $5.0M (Tier 2). Industry: Other.

## Offering

- Filed: 2023-08-25
- Form: 1-A/A
- Accession: 0001493152-23-030138
- Tier: Tier 2
- Total aggregate offering: $5.0M
- Issuer portion: $5.0M
- Price per security: $0.0100
- Securities offered: Equity (common or preferred stock)
- Underwriter: JH Darbie & Co.
- Broker-dealer CRD: 136352
- Audit status: Audited
- Auditor: Rose, Snyder & Jacobs, LLP
- Jurisdictions: 52 states/territories

## Issuer

- CIK: 0001528172
- Organized in: DE
- Incorporated: 2008
- Address: 6320 Canoga Avenue, Woodland Hills, CA, 91367
- Phone: 800-489-4774

## Financial snapshot (as filed)

- Total assets: $1.0M
- Cash & equivalents: $33K
- Total liabilities: $23.2M
- Stockholder equity: $-22.2M
- Revenues: $133K
- Net income: $9.3M

## People (1)

| Name | Role | Location |
| --- | --- | --- |
| Alan Collier Ceo | Signer | Woodland Hills, CA |

## Other Reg A filings by this issuer (3)

| Filed | Form |
| --- | --- |
| [2023-06-14](https://search.stillhousedata.com/rega/0001493152-23-021216) | 1-A/A |
| [2022-05-10](https://search.stillhousedata.com/rega/0001493152-22-012733) | 1-A/A |
| [2022-02-11](https://search.stillhousedata.com/rega/0001493152-22-004106) | 1-A |

## More

- [CIK 1528172 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1528172&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/rega/0001493152-23-030138.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.